| News
DayOne healthtech accelerator launches new offering
31.03.2022
DayOne shares the launch of DayOne Accelerator 2.0, marking a transition to three verticals that will enable the growth of global healthcare and medtech startups at various stages of development.

Three new verticals will support a wider community of innovators from concept to mid-stage ventures. Each selected team will receive equity-free funding up to CHF 100,000 in addition to 1-2-1 coaching, tailored mentoring and training, workspace, industry-wide visibility and access to DayOne’s 2,000+ network of key digital health experts.
Learn more [DayOne Accelerator – Day One]
The three verticals include:
Digital Health Nation
An NTN Innovation Booster powered by Innosuisse for researchers and entrepreneurs with a radical idea to transform digital health and patient care in Switzerland. Stages include identifying customer needs and feasibility, determining profitability and product creation to turn hypotheses into a minimum viable product with up to CHF 20,000 non-dilutive funding.
DayOne Tech
A 12 month program for medtech startups, offering the funding, space (Canton of Jura), and guidance needed to turn prototypes into medical devices ready for market launch. Includes up to 150 hours of coaching and up to CHF 100,000 non-dilutive funding to support ambitious milestones and long term business success.
DayOne Health 4.0
A 12 week intense program for early (pre-seed) to mid-stage (pre-series B) digital health ventures from all over the world looking to scale into a successful pharmaceutical business. Entrepreneurs will gain access to a personal coach and advisors, engage with our Pharma partners along the program to build your business model at their interface and showcase your collaboration proposal at a private Demo Day. You will also receive up to CHF 15,000 non-dilutive funding to work on priority areas and get your venture closer to a potential collaboration with our partners.
Learn more about DayOne Health 4.0.
Located in Europe’s healthtech capital, applicants across all verticals will benefit from unlimited access to world-leading research institutes as well as an extensive pool of specialists and collaborators with which to grow their company.
Interested in applying?
Registration for DayOne Accelerator 2.0 is now open to digital health and medtech startups around the world. Express your interest and join one of Europe’s largest healthcare ecosystems today.
I’m interested! Apply – Day One
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
VectivBio sold for approximately 1 billion dollars
The takeover of VectivBio is now being finalized: the Boston-based firm Ironwood Pharmaceuticals, which specializes in gastrointestinal medicine, has agreed...
Read MoreUniversity of Basel and RocketVax present new Covid vaccine
Researchers from the University of Basel have developed a new concept for a Covid vaccine in collaboration with the biotech...
Read MoreRami Swiss and Elbit Systems now manufacturing in Jura
The newly established company Rami Swiss has inaugurated a new production facility in Courtételle in the canton of Jura together...
Read MoreBasel to become Europe’s Silicon Valley of biotech
Silicon Valley is synonymous with technology and innovation, and home to dozens of Fortune 1000 companies and thousands of startups....
Read MoreRoche and Novartis among global leaders for research spending
In 2022, Roche invested 16 billion euros in research and development overall. This puts the Basel-based life sciences firm in...
Read MoreRoche to found Institute for Human Biology
Roche has announced that it will be establishing the Institute of Human Biology in Basel. Up to 250 employees will...
Read More